The promise of global cervical-cancer prevention

被引:177
作者
Schiffman, M [1 ]
Castle, PE [1 ]
机构
[1] NCI, Hormonal & Reprod Epidemiol Branch, Div Canc Epidemiol & Prevent, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1056/NEJMp058171
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2101 / 2104
页数:4
相关论文
共 3 条
[1]   Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial [J].
Harper, DM ;
Franco, EL ;
Wheeler, C ;
Ferris, DG ;
Jenkins, D ;
Schuind, A ;
Zahaf, T ;
Innis, B ;
Naud, P ;
De Carvalho, NS ;
Roteli-Martins, CM ;
Teixeira, J ;
Blatter, MM ;
Korn, AP ;
Quint, W ;
Dubin, G .
LANCET, 2004, 364 (9447) :1757-1765
[2]   Epidemiologic classification of human papillomavirus types associated with cervical cancer [J].
Muñoz, N ;
Bosch, FX ;
de Sanjosé, S ;
Herrero, R ;
Castellsagué, X ;
Shah, KV ;
Snijders, PJF ;
Meijer, CJLM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :518-527
[3]   Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial [J].
Villa, LL ;
Costa, RLR ;
Petta, CA ;
Andrade, RP ;
Ault, KA ;
Giuliano, AR ;
Wheeler, CM ;
Koutsky, LA ;
Malm, C ;
Lehtinen, M ;
Skjeldestad, FE ;
Olsson, SE ;
Steinwall, M ;
Brown, DR ;
Kurman, R ;
Ronnett, BM ;
Stoler, MH ;
Ferenczy, A ;
Harper, DM ;
Tamms, GM ;
Yu, J ;
Lupinacci, L ;
Railkar, R ;
Taddeo, FJ ;
Jansen, KU ;
Esser, MT ;
Sings, HL ;
Saah, AJ ;
Lupinacci, L .
LANCET ONCOLOGY, 2005, 6 (05) :271-278